These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37392464)

  • 21. Digital health, digital medicine, and digital therapeutics in cardiology: current evidence and future perspective in Japan.
    Nomura A
    Hypertens Res; 2023 Sep; 46(9):2126-2134. PubMed ID: 37258624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Digital therapeutics from bench to bedside.
    Wang C; Lee C; Shin H
    NPJ Digit Med; 2023 Mar; 6(1):38. PubMed ID: 36899073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive survey of the clinical trial Landscape on digital therapeutics.
    Yao H; Liao Z; Zhang X; Zhang X; Li M; You L; Liu Y
    Heliyon; 2024 Aug; 10(16):e36115. PubMed ID: 39224386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apprehensions about Excessive Belief in Digital Therapeutics: Points of Concern Excluding Merits.
    Kim HS
    J Korean Med Sci; 2020 Nov; 35(45):e373. PubMed ID: 33230984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AMCP Partnership Forum: The evolving role of digital therapeutics.
    J Manag Care Spec Pharm; 2022 Jul; 28(7):804-810. PubMed ID: 35699389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digital therapeutics in hypertension: How to make sustainable lifestyle changes.
    Chen C; Liu A; Zhang Z; Chen J; Huang H
    J Clin Hypertens (Greenwich); 2024 Oct; 26(10):1125-1132. PubMed ID: 39248244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. There's an app for that, but nobody's using it: Insights on improving patient access and adherence to digital therapeutics in Germany.
    Dahlhausen F; Zinner M; Bieske L; Ehlers JP; Boehme P; Fehring L
    Digit Health; 2022; 8():20552076221104672. PubMed ID: 35811758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reimbursement of Digital Therapeutics: Future Perspectives in Korea.
    Ju JH; Sim B; Lee J; Lee JY
    Korean Circ J; 2022 Apr; 52(4):265-279. PubMed ID: 35388995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digital Therapeutics for Obesity and Eating-Related Problems.
    Kim M; Choi HJ
    Endocrinol Metab (Seoul); 2021 Apr; 36(2):220-228. PubMed ID: 33761233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Digital Therapeutics for Improving Effectiveness of Pharmaceutical Drugs and Biological Products: Preclinical and Clinical Studies Supporting Development of Drug + Digital Combination Therapies for Chronic Diseases.
    Biskupiak Z; Ha VV; Rohaj A; Bulaj G
    J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Game-based digital therapeutics for children and adolescents: Their therapeutic effects on mental health problems, the sustainability of the therapeutic effects and the transfer of cognitive functions.
    Choi E; Yoon EH; Park MH
    Front Psychiatry; 2022; 13():986687. PubMed ID: 36523871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of digital therapeutics for essential hypertension.
    Nomura A; Tanigawa T; Kario K; Igarashi A
    Hypertens Res; 2022 Oct; 45(10):1538-1548. PubMed ID: 35726085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of digital therapeutics and the changing future of healthcare.
    Dang A; Arora D; Rane P
    J Family Med Prim Care; 2020 May; 9(5):2207-2213. PubMed ID: 32754475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editorial: Digital therapeutics: using software to treat, manage, and prevent disease.
    Smayda KE; Campellone T; Taylor SR; Harris B; Ellis TD; Awad LN
    Front Digit Health; 2023; 5():1261124. PubMed ID: 37818169
    [No Abstract]   [Full Text] [Related]  

  • 36. The current status of breakthrough devices designation in the United States and innovative medical devices designation in Korea for digital health software.
    Woo JH; Kim EC; Kim SM
    Expert Rev Med Devices; 2022 Mar; 19(3):213-228. PubMed ID: 35255755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Empowering Patients One App at a Time: An Introduction to Digital Therapeutics.
    Rahaman T
    Med Ref Serv Q; 2023; 42(3):301-307. PubMed ID: 37459489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of blended care as a mechanism of action in the construction of digital therapeutics.
    Valerio Netto A
    Einstein (Sao Paulo); 2020; 18():eMD5640. PubMed ID: 33237249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world usage of digital health applications (DiGA) in rheumatology: results from a German patient survey.
    Labinsky H; Gupta L; Raimondo MG; Schett G; Knitza J
    Rheumatol Int; 2023 Apr; 43(4):713-719. PubMed ID: 36543961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tracing Digital Therapeutics Research Across Medical Specialties: Evidence from ClinicalTrials.gov.
    Masanneck L; Stern AD
    Clin Pharmacol Ther; 2024 Jul; 116(1):177-185. PubMed ID: 38563641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.